Food-tech start-up Cosaic has announced a successful $6 million seed funding round, led by DSM-Firmenich’s investment arm, to accelerate scale-up of its yeast fermentation platform.

In addition to DSM-Firmenich Ventures, the round saw participation from Swiss deep-tech investor Kickfund, and existing investors Navus Ventures and Zuercher Kantonalbank, among others.

Cosaic said that despite the challenging funding environment for food-tech companies currently, the capital raised highlights investors’ continued support of technologies that are distinctive and commercially viable.

Headquartered in Horgen, Switzerland, Cosaic (formerly Cultivated Biosciences) is developing a ‘new category of food ingredients’ based on yeast fermentation. Its technology platform aims to help manufacturers achieve creaminess, stability and functionality through a single ingredient, addressing formulation challenges that have traditionally been solved using multiple components and additives.

The investment round will support three priorities over the company’s current phase of growth to become market-ready: regulatory work, production scale-up and industrial trials with large clients.

It follows Cosaic’s partnership with Ingredion, announced in late 2025, which provided the start-up with commercial validation. Backing from major players like Ingredion and DSM-Firmenich is helping to accelerate the company’s path from product development to market entry, Cosaic said.

Tomas Turner, co-founder and CEO of Cosaic, commented: “At Cosaic, we are building an ingredient that resolves the trade-offs food companies face every day between clean label, sensory performance and cost. With strong strategic backing and a capital-efficient scale-up model, we are well positioned to move from development to launch readiness.”